Notice NOT-HD-20-046 from the NIH Guide for Grants and Contracts

Notice NOT-HD-20-045 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-092 from the NIH Guide for Grants and Contracts. The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use. Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum. The ultimate goal of this FOA is to bring molecules closer to FDA approval.

Notice NOT-CA-21-026 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-020 from the NIH Guide for Grants and Contracts

Notice NOT-EY-21-007 from the NIH Guide for Grants and Contracts

Notice NOT-GM-21-004 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-018 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-316 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutical-based agents, and pesticides. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy consistent with the product's intended use in humans. For applicants submitting U54 renewal applications, research under this FOA should culminate in an optimized lead compound ready for advanced development. The Centers will contain at least three research projects supported by an administrative core, up to three optional scientific cores, and a research education core. Each research project must include milestones that create discrete go or no-go decision points in a progressive translational study plan.

Competitive Salary: EMBL: Helpdesk Bioinformatician - European Genome-phenome Archive Cambridge, Cambridgeshire, England

Notice NOT-MH-21-110 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-138 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-137 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-135 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-075 from the NIH Guide for Grants and Contracts

Notice NOT-HS-21-005 from the NIH Guide for Grants and Contracts

£37,398 to £44,799: Wellcome Sanger Institute: We are looking for a Senior Bioinformatician to join our Tree of Life and Parasites and Microbes teams. Hinxton, Cambridgeshire (GB)

Competitive Salary: EMBL: User Experience Designer - COVID-19 Data Portal Loc Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: Hybrid Cloud Manager Location: E Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: Ensembl Variation Project Leader Location: Cambridge, Cambridgeshire, England